| pubmed-article:1424674 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1424674 | lifeskim:mentions | umls-concept:C1282359 | lld:lifeskim |
| pubmed-article:1424674 | lifeskim:mentions | umls-concept:C0184511 | lld:lifeskim |
| pubmed-article:1424674 | lifeskim:mentions | umls-concept:C0242656 | lld:lifeskim |
| pubmed-article:1424674 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
| pubmed-article:1424674 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:1424674 | pubmed:dateCreated | 1992-12-18 | lld:pubmed |
| pubmed-article:1424674 | pubmed:abstractText | Cicatricial pemphigoid is an autoimmune systemic disease characterized by chronic conjunctival cicatrization. The natural history is one of variable degrees of progressive scarring of the ocular surface and visual loss. Previous reports have shown systemic chemotherapy to be efficacious in halting cicatrization in progressive cases. This observation makes it of critical importance to be able to detect progression of the disease as early as possible so as to allow for earlier institution of treatment. Our experience in previous studies has led us to believe that disease staging systems currently in use are relatively insensitive in detecting disease progression. We present a revised staging system that combines the strengths of the staging systems in use today and extends their sensitivity. | lld:pubmed |
| pubmed-article:1424674 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1424674 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1424674 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1424674 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1424674 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:1424674 | pubmed:issn | 0277-3740 | lld:pubmed |
| pubmed-article:1424674 | pubmed:author | pubmed-author:FosterC SCS | lld:pubmed |
| pubmed-article:1424674 | pubmed:author | pubmed-author:TauberJJ | lld:pubmed |
| pubmed-article:1424674 | pubmed:author | pubmed-author:JabburNN | lld:pubmed |
| pubmed-article:1424674 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1424674 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:1424674 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1424674 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1424674 | pubmed:pagination | 446-51 | lld:pubmed |
| pubmed-article:1424674 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1424674 | pubmed:meshHeading | pubmed-meshheading:1424674-... | lld:pubmed |
| pubmed-article:1424674 | pubmed:meshHeading | pubmed-meshheading:1424674-... | lld:pubmed |
| pubmed-article:1424674 | pubmed:meshHeading | pubmed-meshheading:1424674-... | lld:pubmed |
| pubmed-article:1424674 | pubmed:meshHeading | pubmed-meshheading:1424674-... | lld:pubmed |
| pubmed-article:1424674 | pubmed:meshHeading | pubmed-meshheading:1424674-... | lld:pubmed |
| pubmed-article:1424674 | pubmed:meshHeading | pubmed-meshheading:1424674-... | lld:pubmed |
| pubmed-article:1424674 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1424674 | pubmed:articleTitle | Improved detection of disease progression in ocular cicatricial pemphigoid. | lld:pubmed |
| pubmed-article:1424674 | pubmed:affiliation | Massachusetts Eye and Ear Infirmary, Boston, Massachusetts 02114. | lld:pubmed |
| pubmed-article:1424674 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1424674 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1424674 | lld:pubmed |
